|
|
Volumn 25, Issue 18, 2007, Pages 2637-2638
|
|
In reply [10]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CETUXIMAB;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUDARABINE;
PACLITAXEL;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER RESEARCH;
CANCER RISK;
COLORECTAL CANCER;
COST EFFECTIVENESS ANALYSIS;
DECISION MAKING;
EVIDENCE BASED PRACTICE;
HEALTH PROGRAM;
HUMAN;
LETTER;
LYMPHATIC LEUKEMIA;
MULTIPLE CYCLE TREATMENT;
OUTCOME ASSESSMENT;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
|
|
EID: 34447261901
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2007.11.5899 Document Type: Letter |
|
Times cited : (3)
|
|
References (4)
|
